Table 2.
Biomarkers |
---|
Oral microbiome (e.g., presence in AD brain) |
Volatile organic compounds (e.g., unique profiles among neurodegenerative diseases) |
Salivary proteomics (e.g., Aβ peptides, tau, and lactoferrin, salivary acetylcholinesterase activity linked to AD) |
Salivary lipidomics (a new frontier for AD) |